Gary Gilkeson to Transplantation, Homologous
This is a "connection" page, showing publications Gary Gilkeson has written about Transplantation, Homologous.
Connection Strength
0.245
-
Differential effect of allogeneic versus syngeneic mesenchymal stem cell transplantation in MRL/lpr and (NZB/NZW)F1 mice. Clin Immunol. 2012 Nov; 145(2):142-52.
Score: 0.095
-
A Long-Term Follow-Up Study of Allogeneic Mesenchymal Stem/Stromal Cell Transplantation in Patients with Drug-Resistant Systemic Lupus Erythematosus. Stem Cell Reports. 2018 03 13; 10(3):933-941.
Score: 0.035
-
Allogeneic mesenchymal stem cell transplantation for lupus nephritis patients refractory to conventional therapy. Clin Rheumatol. 2014 Nov; 33(11):1611-9.
Score: 0.027
-
Allogeneic mesenchymal stem cell transplantation in severe and refractory systemic lupus erythematosus: 4 years of experience. Cell Transplant. 2013; 22(12):2267-77.
Score: 0.024
-
Allogenic mesenchymal stem cell transplantation ameliorates nephritis in lupus mice via inhibition of B-cell activation. Cell Transplant. 2013; 22(12):2279-90.
Score: 0.024
-
Umbilical cord mesenchymal stem cell transplantation in severe and refractory systemic lupus erythematosus. Arthritis Rheum. 2010 Aug; 62(8):2467-75.
Score: 0.020
-
Allogenic mesenchymal stem cells transplantation in refractory systemic lupus erythematosus: a pilot clinical study. Ann Rheum Dis. 2010 Aug; 69(8):1423-9.
Score: 0.020